S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › THRU › Research report
← THRU page
XStocksXray
Market X-Ray report · 20 October 2026

Thruvision Group PLC (THRU)

London Exchange · UK · prices in GBX · close of 20 Oct 2026

Key indicators

Last closeGBX 1.950
52-week range0.500 – 3.400
Return, 1 month / 3 months−15.2% / +188.9%
Return, 1 year / 3 years+69.6% / −91.7%
TrendAbove 200-day, below 50-day
RSI (14)44
Volatility (1 year)108.2%
Worst drawdown (1 year)-52.3%
Average daily value traded19.34M GBX
Dividend yield–

Market X-Ray price-based

64/ 100 · High confidence · ahead of 74% of stocks on this exchange
Trend75
Momentum98
Stability (higher is calmer)11
Liquidity79
Income–

Five-year price chart navy: price · brown: 200-day average

-1.518.0017.5127.0336.542021-102023-012024-042025-072026-10

About the company

Thruvision Group makes people-screening cameras that use passive terahertz imaging to detect objects concealed under clothing without any radiation being emitted. Its equipment is used by customs and border authorities, prisons, and security operators to check people for contraband, and by retailers to spot theft. The company is based in the United Kingdom and supplies both hardware and related support to government and commercial customers around the world.

Thruvision Group PLC trades under the code THRU on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Thruvision Group PLC (THRU) trades on the London Exchange in UK. It last closed at GBX 1.950 on 20 October 2026.

Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 982 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 69.6% and over the last three months it rose 188.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Thruvision Group PLC (THRU)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend75 · StrongTrading above its long-term averages and near its highs.
Above 200-day average73.5%
From 52-week high-33.9%
Momentum98 · StrongRising faster than most stocks on this exchange.
3-month return188.9%
6-month return129.4%
12-month return, skipping the last month100.0%
Stability (higher is calmer)11 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)108.2%
Worst drawdown, 1 year (smaller is calmer)-52.3%
Liquidity79 · StrongTrades actively.
Average daily value traded19.34M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+5.4%
1 month−15.2%
3 months+188.9%
6 months+129.4%
1 year+69.6%
3 years−91.7%
5 years−90.1%

Signals

50-day / 200-day average2.013 / 1.124
Golden / death cross (60 days)Golden, 36 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.227

Technical summary

DailyNeutral6 bullish · 3 neutral · 7 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyNeutral4 bullish · 1 neutral · 3 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026